Stay updated with breaking news from Development Kathrin Jansen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific COVID-19 vaccine candidate, they announced in a news release on Tuesday.
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.